Carregant...
ALS drug development: Reflections from the past and a way forward
Tremendous advances in our understanding of pathogenesis of amyotrophic lateral sclerosis (ALS) have provided a rich pipeline of drugs for clinical trialists. At least 32 unique compounds have been tested. Nevertheless, riluzole is currently the only treatment that prolongs survival. We present a cr...
Guardat en:
| Publicat a: | Neurotherapeutics |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer New York
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514695/ https://ncbi.nlm.nih.gov/pubmed/19019302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2008.08.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|